This study underscores NAT10’s pivotal role in modulating the prostate cancer immune microenvironment, offering insights into the immune desert phenomenon and identifying NAT10 as a promising therapeutic target for improving immunotherapy efficacy. Here, NAT10 is linked to prostate cancer.